Richard Francis Salary and Compensation - TEVA PHARMACEUTICAL INDUSTRIES LTD CEO Pay 2024

In fiscal year 2024, Richard Francis, President and Chief Executive Officer of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), received total compensation of $15.5 million.

Richard Francis's compensation breakdown includes: base salary of $1.6 million, bonus of $1.5 million, stock awards valued at $9.0 million, non-equity incentive compensation of $2.9 million, and other compensation of $534K.

Compared to fiscal year 2023, Richard Francis's total compensation decreased 40% from $25.7 million to $15.5 million.

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Executive Pay 2024

TEVA PHARMACEUTICAL INDUSTRIES LTD's top 5 named executive officers received combined total compensation of $38.1 million in fiscal year 2024.

The named executive officers disclosed in TEVA PHARMACEUTICAL INDUSTRIES LTD's 2024 proxy statement are:Richard Francis (President and Chief Executive Officer) with total compensation of $15.5 million, Eli Kalif (Executive Vice President Chief Financial Officer) with total compensation of $6.2 million, Eric Hughes (Executive Vice President Global R&D and Chief Medical Officer) with total compensation of $5.8 million, Richard Daniell (Executive Vice President European Commercial) with total compensation of $5.4 million, and Christine Fox (Executive Vice President US Commercial) with total compensation of $5.2 million.